Efficacy of Etanercept in the Treatment of the Entheseal Pathology in Resistant Spondylarthropathy: A Clinical and Magnetic Resonance Imaging Study

Arthritis and Rheumatism

Volumn 44, Issue 9, 2001, Pages 2112-2117

  Marzo Ortega, Helena ^a   McGonagle, Dennis ^a   O'Connor, Philip ^b   Emery, Paul ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b LEEDS GENERAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRHEUMATIC AGENT; IMMUNOGLOBULIN G; TNFR FC FUSION PROTEIN; TNFR-FC FUSION PROTEIN; TUMOR NECROSIS FACTOR RECEPTOR;

ADULT; ANKYLOSING SPONDYLITIS; ARTICLE; CLINICAL TRIAL; FEMALE; FINGER JOINT; HOSPITALIZATION; HUMAN; LUMBAR VERTEBRA; MALE; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; SACROILIAC JOINT; TREATMENT OUTCOME;

ADULT; ANTIRHEUMATIC AGENTS; FEMALE; FINGER JOINT; HUMANS; IMMUNOGLOBULIN G; LUMBAR VERTEBRAE; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; RECEPTORS, TUMOR NECROSIS FACTOR; SACROILIAC JOINT; SEVERITY OF ILLNESS INDEX; SPONDYLITIS, ANKYLOSING; TREATMENT OUTCOME;

EID: 0035459313     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(200109)44:9<2112::AID-ART363>3.0.CO;2-H     Document Type: Article

References (16)

1. Calin A. Ankylosing spondylitis. In: Maddison PJ, Isenberg DA, Woo P, Glass DN, editors. Oxford textbook of rheumatology. Oxford, New York, Tokyo: Oxford University Press; 1993. p. 681-90.
2. Braun J, Bollow M, Eggens U, König H, Distler A, Sieper J. Use of dynamic magnetic resonance imaging with fast imaging in the detection of early and advanced sacroiliitis in spondylarthropathy patients. Arthritis Rheum 1994;37:1039-45.
3. McGonagle D, Gibbon W, O'Connor P, Green M, Pease C, Emery P. Characteristic magnetic resonance imaging entheseal changes of knee synovitis in spondylarthropathy. Arthritis Rheum 1998;41: 694-700.
4. Brandt J, Haibel H, Comely D, Golder W, Gonzalez J, Reddig J, et al. Successful treatment of active ankylosing spondylitis with the anti-tumor necrosis factor a monoclonal antibody infliximab. Arthritis Rheum 2000;43:1346-52.
5. Van den Bosch F, Kruithof E, Baeten D, de Keyser F, Mielants H, Veys E. Effects of a loading dose regimen of three infusions of chimcric monoclonal antibody to tumour necrosis factor alpha (infliximab) in spondyloarthropathy: an open pilot study. Ann Rheum Dis 2000;59:428-33.
6. Ulfgren A-K, Andersson U, Engström M, Klareskog L, Maini RN, Taylor PC. Systemic anti-tumor necrosis factor a therapy in rheumatoid arthritis down-regulates synovial tumor necrosis factor a synthesis. Arthritis Rheum 2000;43:2391-6.
7. Dougados M, van der Linden S, Juhlin R, Huitdfeldt B, Amor B, Calin A, et al. The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum 1991;34:1218-27.
8. Calin A, Porta J, Fries JF, Schurman J. Clinical history as a screening test for ankylosing spondylitis. JAMA 1977;237:2613-4.
9. Calin A, Garrett S, Whitelock H, Kennedy LG, O'Hea J, Mallorie P, et al. A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol 1994;21:2281-5.
10. Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A. A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 1994;21:2286-91.
11. Helliwell PS, Doward L, Whalley D, Tennant A, McKenna S, Reynolds S, et al. Psychometric and scaling properties of a new quality of life instrument specific to ankylosing spondylitis [abstract]. Arthritis Rheum 1999;42 Suppl 9:S72.
12. Clegg DO, Reda DJ, Abdellatif M. Comparison of sulfasalazine and placebo for the treatment of axial and peripheral articular manifestations of the seronegative spondylarthropathies. Arthritis Rheum 1999;42:2325-9.
13. Braun J, Bollow M, Neure L, Seipelt E, Seyrekbasan F, Herbst H, et al. Use of immunohistologic and in situ hybridization techniques in the examination of sacroiliac joint biopsy specimens from patients with ankylosing spondylitis. Arthritis Rheum 1995;38: 499-505.
14. Bollow M, Fischer T, Rcisshaucr H, Backhaus M, Sieper J, Hamm B, et al. Quantitative analyses of sacroiliac biopsies in spondyloarthropathies: T cells and macrophages predominate in early and active sacroiliitis - cellularity correlates with the degree of enhancement detected by magnetic resonance imaging. Ann Rheum Dis 2000;59:135-40.
15. Marzo H, McGonagle D, O'Connor P, Green MJ, Pease C, Wakefield R, et al. Fat suppressed MRI in spinal disease in early spondyloarthropathy [abstract]. Arthritis Rheum 1998;41 Suppl 9:S355.
16. McGonagle D, Emery P. Enthesitis, osteitis, microbes, biomechanics and immune reactivity in ankylosing spondylitis. J Rheumatol 2000;27:2302-4.